A man who took radioactive medication in his final days was cremated in 2017, a mistake that released potentially dangerous Lutetium 177 into the environment.
This alarming case, reported in a new research letter this week, illustrates the collateral risks potentially posed by on average 18.6 million nuclear medicine procedures involving radiopharmaceuticals performed in the US every year.
While rules regulate how these drugs are administered to living patients, the picture can become less clear when those patients die, thanks to a patchwork of different laws and standards in each state – not to mention situations like the 69-year-old man, whose radioactive status simply slipped through the cracks.
"Radiopharmaceuticals present a unique and often overlooked postmortem safety challenge," researchers from the Mayo Clinic explain in a case note.
